38
https://pubmed.ncbi.nlm.nih.gov/38094682
PCSK9, which regulates cholesterol metabolism, may be a promising target to reduce age-related cardiovascular dysfunction, as its levels positively correlate with increasing age and cardiovascular impairment in humans and rats.